Exelixis
The Senior Scientist II leads pharmacology research efforts to support Discovery and Development projects, focusing on in vivo experiments and establishing PK/PD/Efficacy relationships for therapeutic candidates. This role involves representing the Pharmacology function on project teams, providing scientific support, and collaborating with internal and external partners to advance oncology drug discovery. The position requires managing animal facility operations, ensuring regulatory compliance, and contributing to IND filing documentation.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
16% above the average for this role
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Director/Senior Director, In Vivo Pharmacology
Rezo Therapeutics
Vice President, Preclinical & Clinical Development
Scripps Research
Scientist, In Vivo Pharmacology
AstraZeneca
Senior Clinical Pharmacologist
Regeneron Pharmaceuticals
Associate Director, In‑Vivo Pharmacology
Bristol Myers Squibb
Associate Director
Regeneron Pharmaceuticals